BeStock  
Stocks › Biotechnology › SNDX

Syndax Pharmaceuticals SNDX

US equityMarket cap rank #3319Biotechnology
$8.72 −$0.41 (-4.49%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $8.72 0.00%
Open$9.07
Prev close$9.13
Day range$8.69 – $9.27
Volume2.18M
Market cap$785.05M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-4.0x
CheapRich

Above its usual level · 66th percentile, 5-year average 5.1x

Price / book-49.5x
CheapRich

Near the bottom of its 5-year range · 1st percentile, 5-year average 12.4x

#5264 of 5335 stocks by PB (1 = cheapest)

Price / sales2.9x
CheapRich

Near the bottom of its 5-year range · 0th percentile, 5-year average 44.7x

#3128 of 5159 stocks by PS (1 = cheapest)

P/E over five years

-39x24x88x151xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$12.23
Price vs. fair value-28.7%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB -49.48 – 12.36 1% (cheaper than usual) #5264 of 5335 (1 = cheapest)
PE -3.99 -6.12 5.07 66% (pricier than usual) –
PS 2.94 2.10 44.68 0% (cheaper than usual) #3128 of 5159 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on SNDX.

Sign in to join the discussion.

Scroll to Top